甲状腺结节恶性预测的临床研究:改良评分与2017年美国放射学会甲状腺影像报告和数据系统超声词典的比较
本研究利用灰阶超声、超声造影和剪切波弹性成像构建改良甲状腺影像报告和数据系统评分,并与2017版美国放射学会甲状腺影像报告和数据系统主观评分比较,发现联合剪切波弹性成像和超声造影可提高4类和5类结节的恶性率,评分2的曲线下面积为0.899,高于评分1的0.862(P>0.05)。
要点
- 剪切波弹性成像和超声造影用于下调4类和5类结节后,恶性率从单独ACR TI-RADS的47.6%升至49.4%。
- 改良TI-RADS调整3类结节后,3类结节恶性率从13.9%-20.0%升高。
- 评分2曲线下面积0.899(95%CI 86.1%-93.6%),高于评分1的0.862(95%CI 81.9%-90.6%;P>0.05)。
核心结论
- 基于ACR TI-RADS联合剪切波弹性成像和超声造影(增强模式)的改良TI-RADS可能有助于减少对良性结节的活检并在临床实践中实施一致的随访。
研究设计与样本
- 临床研究,利用灰阶超声、超声造影和剪切波弹性成像图像构建改良TI-RADS评分并与2017版ACR TI-RADS主观评分比较。
诊断标准与关键数值
- 评分1(ACR TI-RADS)以4.5点为最佳截断值预测恶性,准确率75.6%、敏感度85.0%、特异度71.6%。
- 评分2(ACR TI-RADS+SWE+CEUS)以5.5点为最佳截断值预测恶性,准确率84.9%、敏感度81.0%、特异度86.6%。
- 评分2曲线下面积0.899(95%CI 86.1%-93.6%),高于评分1的0.862(95%CI 81.9%-90.6%;P>0.05)。
- 单独ACR TI-RADS评估4类和5类结节恶性率为47.6%,联合SWE和CEUS(增强模式)后升至49.4%。
- 改良TI-RADS调整3类结节后,3类结节恶性率从13.9%-20.0%升高。
临床应用与阅片要点
- 作者认为基于ACR TI-RADS+SWE+CEUS(增强模式)的改良TI-RADS可能有助于减少对良性结节的活检并在临床实践中实施一致的随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The clinical importance of thyroid nodules rests with the need to exclude thyroid cancer. In the present study, we developed a modified Thyroid Imaging Reporting and Data System (TI-RADS) score using gray-scale ultrasound, contrast-enhanced ultrasound (CEUS) and shear-wave elastography (SWE) images to predict malignancy of thyroid nodules and compared this modified score system with the subjective scoring criteria based on the Thyroid Imaging Reporting and Data System (TI-RADS, 2017 edition). The results revealed that by using SWE and CEUS (enhanced pattern) to downgrade TI-RADS category 4 and 5 nodules, the malignancy rate for TI-RADS category 4 and 5 nodules increased from 47.6% with American College of Radiology (ACR) TI-RADS assessment alone to 49.4% with ACR TI-RADS combined with shear wave elastography (SWE) and CEUS (enhanced pattern). Likewise, by using the modified TI-RADS to adjust TI-RADS category 3 nodules, the malignancy rate for TI-RADS category 3 nodules increased from 13.9%-20.0%. The discriminating power for detection of malignancy of the variable score 2 (ACR TI-RADS + SWE + CEUS), with an area under the curve (AUC) of 0.899 (95% confidence interval [CI]: 86.1%-93.6%), was higher than that of score 1 (ACR TI-RADS), with an AUC of 0.862 (95% CI: 81.9%-90.6%; p > 0.05). With a point 4.5 as the optimal cutoff value, a score of 1 predicted malignancy with an accuracy of 75.6%, sensitivity of 85.0% and specificity of 71.6%. However, with a point 5.5 as the optimal cutoff value, a score of 2 predicted malignancy with an accuracy of 84.9%, sensitivity of 81.0% and specificity of 86.6%. The modified TI-RADS based on ACR TI-RADS + SWE + CEUS (enhanced pattern) could contribute to a reduction in the number of biopsies performed on benign nodules and the implementation of consistent follow-up in clinical practice.
引用
- Jin ZQ, Yu HZ, Mo CJ, et al. Clinical Study of the Prediction of Malignancy in Thyroid Nodules: Modified Score versus 2017 American College of Radiology's Thyroid Imaging Reporting and Data System Ultrasound Lexicon. Ultrasound Med Biol. 2019. PMID: 31064698. doi:10.1016/j.ultrasmedbio.2019.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。